Author Hasenclever, Dirk
-
2000 | Conference Abstract
Dose escalated BEACOPP chemotherapy improves failure free survival in advanced Hodgkin's disease: Updated results of the German Hodgkin's Lymphoma Study Group.
Diehl, V.; Franklin, J.; Sieber, M.; Hasenclever, D.; Wolf, J.; Engert, A. & Hermann, R. et al. (2000)
Blood, 96(11) pp. 576A-+.
Washington: Amer Soc Hematology.
Details WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rudolph, C. & Reiser, M. et al. (2004)
Blood, 104(3) pp. 626-633. DOI: https://doi.org/10.1182/blood-2003-06-2094
Details DOI PMID PMC WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rube, C. & Rudolph, C. et al. (2004)
Blood, 104(3) pp. 634-641. DOI: https://doi.org/10.1182/blood-2003-06-2095
Details DOI PMID PMC WoS
-
2006 | Journal Article
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Hummel, M.; Bentink, S.; Berger, H.; Klapper, W.; Wessendorf, S.; Barth, T. F. E. & Bernd, H. W. et al. (2006)
New England Journal of Medicine, 354(23) pp. 2419-2430. DOI: https://doi.org/10.1056/NEJMoa055351
Details DOI PMID PMC WoS
-
2008 | Conference Abstract
Different subtypes of aggressive B cell lymphomas share an epigenetic signature enriched for polycomb targets in stem cells
Martin-Subero, J. I.; Kreuz, M.; Bibikova, M.; Bentink, S.; Klapper, W.; Wickham-Garcia, E. & Rosolowski, M. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2008 | Journal Article
Pathway activation patterns in diffuse large B-cell lymphomas
Bentink, S.; Wessendorf, S.; Schwaenen, C.; Rosolowski, M.; Klapper, W.; Rosenwald, A. & Ott, G. et al. (2008)
Leukemia, 22(9) pp. 1746-1754. DOI: https://doi.org/10.1038/leu.2008.166
Details DOI PMID PMC WoS
-
2009 | Journal Article
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Engert, A.; Diehl, V.; Franklin, J.; Lohri, A.; Doerken, B.; Ludwig, W.-D. & Koch, P. et al. (2009)
Journal of Clinical Oncology, 27(27) pp. 4548-4554. DOI: https://doi.org/10.1200/JCO.2008.19.8820
Details DOI PMID PMC WoS
-
2009 | Journal Article
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
Martin-Subero, J. I.; Kreuz, M.; Bibikova, M.; Bentink, S.; Ammerpohl, O.; Wickham-Garcia, E. & Rosolowski, M. et al. (2009)
Blood, 113(11) pp. 2488-2497. DOI: https://doi.org/10.1182/blood-2008-04-152900
Details DOI PMID PMC WoS
-
2011 | Journal Article
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults
Salaverria, I.; Philipp, C.; Oschlies, I.; Kohler, C. W.; Kreuz, M.; Szczepanowski, M. & Burkhardt, B. et al. (2011)
Blood, 118(1) pp. 139-147. DOI: https://doi.org/10.1182/blood-2011-01-330795
Details DOI PMID PMC WoS
-
2012 | Journal Article
Remote ischaemic preconditioning for heart surgery
Meybohm, P.; Zacharowski, K.; Cremer, J.; Roesner, J.; Kletzin, F.; Schaelte, G. & Felzen, M. et al. (2012)
European Heart Journal, 33(12) pp. 1423-+.
Details PMID PMC WoS
-
2012 | Journal Article
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing
Richter, J.; Schlesner, M.; Hoffmann, S.; Kreuz, M.; Leich, E.; Burkhardt, B. & Rosolowski, M. et al. (2012)
Nature Genetics, 44(12) pp. 1316-1320. DOI: https://doi.org/10.1038/ng.2469
Details DOI PMID PMC WoS
-
2012 | Journal Article
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma
Klapper, W.; Kreuz, M.; Kohler, C. W.; Burkhardt, B.; Szczepanowski, M.; Salaverria, I. & Hummel, M. et al. (2012)
Blood, 119(8) pp. 1882-1887. DOI: https://doi.org/10.1182/blood-2011-10-388470
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Aukema, S. M.; Kreuz, M.; Kohler, C. W.; Rosolowski, M.; Hasenclever, D.; Hummel, M. & Kueppers, R. et al. (2014)
Haematologica, 99(4) pp. 726-735. DOI: https://doi.org/10.3324/haematol.2013.091827
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL
Hohloch, K.; Zwick, C.; Ziepert, M.; Hasenclever, D.; Kaiser, U.; Engert, A. & Hoeffkes, H.-G. et al. (2014)
SpringerPlus, 3 art. 5. DOI: https://doi.org/10.1186/2193-1801-3-5
Details DOI PMID PMC WoS
-
2015 | Journal Article |
A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery
Meybohm, P.; Bein, B.; Brosteanu, O.; Cremer, J.; Gruenewald, M.; Stoppe, C. & Coburn, M. et al. (2015)
New England Journal of Medicine, 373(15) pp. 1397-1407. DOI: https://doi.org/10.1056/NEJMoa1413579
Details DOI PMID PMC WoS
-
2016 | Journal Article | Research Paper
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma
Hohloch, K.; Zeynalova, S.; Chapuy, B. ; Pfreundschuh, M.; Loeffler, M.; Ziepert, M. & Feller, A. C. et al. (2016)
Annals of Hematology, 95(7) pp. 1121-1128. DOI: https://doi.org/10.1007/s00277-016-2671-5
Details DOI PMID PMC WoS
-
2018 | Journal Article
RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study: Myocardial Dysfunction, Postoperative Neurocognitive Dysfunction, and 1 Year Follow‐Up
Meybohm, P.; Kohlhaas, M.; Stoppe, C.; Gruenewald, M.; Renner, J.; Bein, B. & Albrecht, M. et al. (2018)
Journal of the American Heart Association, 7(7). DOI: https://doi.org/10.1161/JAHA.117.008077
Details DOI
-
2018 | Journal Article
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Be
Pouleur, A.-C.; Anker, S. ; Brito, D.; Brosteanu, O.; Hasenclever, D.; Casadei, B. & Edelmann, F. et al. (2018)
ESC Heart Failure, 5(5) pp. 830-841. DOI: https://doi.org/10.1002/ehf2.12306
Details DOI
-
2019 | Journal Article |
Genome-wide association study of myocardial infarction, atrial fibrillation, acute stroke, acute kidney injury and delirium after cardiac surgery – a sub-analysis of the RIPHeart-Study
Westphal, S.; Stoppe, C.; Gruenewald, M.; Bein, B.; Renner, J.; Cremer, J. & Coburn, M. et al. (2019)
BMC Cardiovascular Disorders, 19(1) art. 26. DOI: https://doi.org/10.1186/s12872-019-1002-x
Details DOI